The thiazole derivative cataloged under CAS 108-42-9 and commonly referenced by its IUPAC designation 2-bromo-1,3-thiazol-4-amine is supplied as a crystalline solid with a molecular weight of 179.04 g·mol⁻¹. The compound is manufactured under a quality management system aligned with ISO 9001:2015 and is available in batch sizes from 500 g pilot quantities to 25 kg production-scale drums. A representative lot release specification includes an HPLC purity of ≥98.5% (area%, 254 nm), melting point range 104–107 °C determined by USP ϰ741ϱ, water content ≤0.3% by Karl Fischer coulometry per ASTM E1064-18, and heavy metals (as Pb) ≤10 ppm via ICP-MS compliant with USP ϰ233ϱ. Trace primary alkyl bromides from the synthetic pathway are controlled to a threshold of ≤50 ppm by GC-FID headspace analysis, a critical boundary in downstream amination reactions where such electrophilic impurities can generate genotoxic side-products at the parts-per-million level.
Purity Profiling and Residual Solvent Fingerprinting After Kilo-Scale Bromination
Batch homogeneity across scale transitions—from 22 L round-bottom flasks to 100 L glass-lined reactors—depends on the management of exothermic excursions during the diazotization-bromination sequence that introduces the halogen at the 2-position. Plant data from 316L stainless steel batch reactors with jacket cooling capacity of 3.5 kW·m⁻²·K⁻¹ show that a controlled addition rate of bromine solution at 0.45–0.55 kg·min⁻¹, while maintaining internal temperature at −5 to 0 °C, minimizes the formation of the 2,5-dibromo derivative, which is difficult to reject below 1.5% by recrystallization from toluene/hexane mixtures. Residual toluene and hexane are quantified by headspace GC-MS against a 1000 µg·mL⁻¹ mixed standard, with acceptance criteria of ≤890 ppm and ≤290 ppm respectively, conforming to ICH Q3C (R8) Class 2 solvent limits. Traces of dimethylformamide derived from the workup are held below 880 ppm.
What Differentiates 4-Amino-2-Bromothiazole from the 2-Amino-4-Bromo Isomer in Palladium-Mediated Bond Constructions?
The regiochemical arrangement exerts a pronounced influence on oxidative addition kinetics at Pd(0). For the 4-amino-2-bromo substitution pattern, the C–Br bond at the 2-position is activated by the adjacent sulfur atom, and the primary amine at the 4-position provides a lower Hammett σmeta value than the corresponding amino group at the 2-position would. Comparative kinetic profiling using Pd2(dba)3/XPhos catalyst systems in toluene at 90 °C shows a t1/2 for Buchwald-Hartwig amination of 2.8 h for 4-amino-2-bromothiazole versus 4.7 h for the 2-amino-4-bromo isomer with morpholine as the nucleophile under identical conditions (conversion to monoarylated product tracked by LC-MS at 215 nm). This translates to a space-time yield improvement of roughly 68% in continuous-flow systems when targeting API intermediates where the free amine must remain intact. In contrast, for Sonogashira alkynylation, the 2-amino-4-bromo congener exhibits a faster coupling rate due to reduced steric shielding of the 4-position, a factor that is exploited in the synthesis of fused thiazolopyrimidines but which is disadvantageous when a vacant 4-amino handle is required for late-stage diversification.
| Parameter | 4-Amino-2-bromothiazole | 2-Amino-4-bromothiazole |
|---|---|---|
| CAS RN | 108-42-9 | 95-13-6 |
| Oxidative addition t1/2 with Pd/XPhos (morpholine) | 2.8 h | 4.7 h |
| Preferred cross-coupling type | Buchwald-Hartwig, Suzuki-Miyaura at C2 | Sonogashira, Ullmann at C4 |
| Amine protection requirement in multi-step sequences | Not strictly required under anhydrous conditions | Often protected as acetamide due to increased nucleophilicity |
| Typical melting point (°C) | 104–107 | 164–166 |
| Stability in DMSO solution at 25°C (purity loss after 48 h) | <0.3% | 2.1% (decomposition via disulfide bridging) |
In the assembly of Bcr-Abl allosteric inhibitors containing a thiazole hinge-binding motif, the unprotected 4-amino group is retained during Suzuki coupling of the 2-bromo moiety with arylboronic acids, a salient process advantage that eliminates a deprotection step and its accompanying 1–2% yield penalty. Regioisomeric selection has been documented in patent literature for kinase inhibitor scaffolds where the thiazole NH2 participates in a critical hydrogen-bond network with a kinase backbone carbonyl; the 4-amino orientation projects the donor pair into the solvent-exposed region without sterically clashing with the gatekeeper residue, whereas the 2-amino orientation forces a suboptimal torsion in the hinge region.
When Storage Conditions Exceed 25 °C at Ambient Humidity for Extended Schedules
Stability chambers set at 40 °C / 75% RH per ICH Q1A(R2) guidelines reveal that the primary degradation pathway for 4-amino-2-bromothiazole under open-cap conditions is hydrolytic debromination, producing 4-amino-2-hydroxythiazole (detected as a m/z 117 [M+H]⁺ peak on LC-TOF). After 90 days the degradation product reaches 2.3% area, exceeding the typical API intermediate acceptance threshold of ≤1.0% for individual unspecified impurities. Consequently, the compound is packaged in double low-density polyethylene liners inside UN-rated fiber drums, with a desiccant bag added for shipments to regions with relative humidity consistently above 60%. The release of corrosive hydrogen bromide gas is negligible below 30 °C but accelerates sharply between 45–50 °C, posing headspace corrosion risks to aluminum-sealed containers; fluorinated high-density polyethylene containers with an EVOH barrier layer are recommended for tropical climate storage exceeding 90-day cycles.
Process Analytical Technology and In-Process Control During Vacuum Drying
Drying under reduced pressure (≤50 mbar) at 35–40 °C for 12–16 h is required after the final aqueous ethanol wash to achieve the water specification. In-line NIR probes (Bruker Matrix-F, 4000–12000 cm⁻¹ range) embedded in a 200 L Büchi agitated nutsche filter-dryer provide real-time tracking of the O–H overtone band at 5150 cm⁻¹, enabling automatic termination of the drying cycle when the predicted KF value falls below 0.3%. This closed-loop control has reduced lot-to-lot moisture variability from ±0.18% (using timed dry cycles) to ±0.06%, which is critical in subsequent lithiation chemistry where residual water quenches the organometallic reagent and generates the des-bromo byproduct.
Trace Elemental Impurity Control for Pharmaceutical Intermediate Applications
Compliance with ICH Q3D (R2) requires that the finished intermediate does not contribute cumulative elemental risks to the final drug substance. Typical batch analyses performed by ICP-MS after microwave-assisted acid digestion show cadmium (≤0.10 ppm), lead (≤0.75 ppm), arsenic (≤0.30 ppm), and mercury (≤0.07 ppm), falling well within Option 2A concentration limits for an intermediate that may represent up to 10% by weight of the final API. Palladium from earlier catalytic steps is not a concern as no Pd is used in the synthetic sequence; however, iron contamination introduced during bromination in glass-lined steel vessels is consistently found at 2–4 ppm and is controlled to a specification ceiling of ≤15 ppm, as elevated iron promotes radical-mediated decomposition of the thiazole ring under acidic conditions. The method conforms to USP ϰ233ϱ using a validated 0.05–5.0 ppm linear range with R² = 0.9994.
Production lines that use 4-amino-2-bromothiazole as a starting material for active pharmaceutical ingredients subject to EU GMP Part II (ICH Q7 Q&A) may require a vendor qualification audit of the bromination step. Certificate of analysis sheets include a statement of conductivity (≤10 μS·cm⁻¹ in a 10% methanol solution) to rule out ionic contamination from incomplete wash removal, a factor that influences crystallinity of the downstream product in antisolvent crystallization. Additionally, a sulfated ash residue on ignition at 600 °C following the harmonized procedure of Ph.Eur. 2.4.14 is reported as ≤0.5%.
When the compound is employed as a building block for agrochemicals—specifically for succinate dehydrogenase inhibitor (SDHI) fungicide architectures—the emphasis in specification shifts toward the limitation of the dibromo congener and the 2,4-diamino impurity that could give rise to bis-triazole off-pathway products. In large-scale campaigns exceeding 500 kg, a preparative HPLC step on a Novasep Hipersep unit with a C18 (10 μm, 20 × 25 cm) column has been costed-in to reduce the dibrominated impurity from 0.8% to ≤0.15%, a purity envelope that translates to a 7% yield improvement in the subsequent fungicide assembly and avoids a secondary column chromatography at the final product stage.
| Test Parameter | Acceptance Criterion | Result | Test Method |
|---|---|---|---|
| Appearance | Pale yellow to off-white crystalline powder | Conforms | Visual / USP ϰ695ϱ |
| Identity (FT-IR) | Matches reference spectrum (principal peaks at 3420, 1635, 1490 cm⁻¹) | Conforms | USP ϰ197ϱ |
| Assay (HPLC, 254 nm) | ≥98.5% | 99.1% | USP ϰ621ϱ |
| Melting Point (capillary) | 104–107 °C | 105.8–106.4 °C | USP ϰ741ϱ |
| Water (KF, coulometric) | ≤0.3% | 0.12% | ASTM E1064-18 |
| Residue on Ignition | ≤0.5% | 0.09% | Ph.Eur. 2.4.14 |
| Heavy Metals (as Pb) | ≤10 ppm | <5 ppm | USP ϰ233ϱ |
| Residual Toluene | ≤890 ppm | 210 ppm | GC-HS, ICH Q3C |
| Dibromo impurity (2,5-dibromo-4-aminothiazole) | ≤1.0% | 0.18% | HPLC Area% |
Incompatibility with amine-based strong bases under elevated temperature warrants attention during reaction design. When 4-amino-2-bromothiazole is exposed to sodium amide or lithium diisopropylamide at temperatures above −10 °C, ring-opening fragmentation competes with deprotonation, generating thioamide by-products that co-elute with the desired product in silica gel chromatography. Operational experience from pilot plants indicates that maintaining lithiation at −78 to −70 °C in THF, using freshly titrated butyllithium, suppresses this pathway effectively, but the addition rate must still not exceed 0.1 eq·min⁻¹ to avoid a transient temperature spike that degrades the ring. This sensitivity to nucleophilic bases constitutes a key differentiator from 2-amino-4-chlorothiazole, which shows greater robustness towards lithiation and is often preferred when such transformations are unavoidable.
For researchers comparing building blocks for DNA-encoded library synthesis, 4-amino-2-bromothiazole offers a unique combination of a Br handle for on-DNA Suzuki coupling and a free primary amine for Fmoc-based capture and release steps without requiring a masked amine equivalent that would add two synthetic transformations. The Brønsted basicity of the amino group, however, limits the range of water-compatible coupling conditions usable in aqueous DMF/DNA mixtures; published data for this specific configuration under DNA-compatible conditions is limited to pH ranges 8.5–10.0, where the amine remains partially protonated but the palladium catalyst retains sufficient activity for coupling at 60 °C in a 24 h cycle.